Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
RECRUITING
NCT06209359
PHASE1

Mechanisms of Diuretic Resistance in Heart Failure, Aim 3

Sponsor: Yale University

View on ClinicalTrials.gov

Summary

Randomized double-blind placebo-controlled crossover study design

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

50

Start Date

2024-07-24

Completion Date

2028-03-01

Last Updated

2024-10-08

Healthy Volunteers

No

Interventions

DRUG

Ammonium Chloride

Participants will be randomized to receive either ammonium chloride or placebo. Participants will receive randomized drug in combination with IV bumetanide, bendroflumethiazide, and amiloride. Following a washout period, participants will be crossed over to the alternate drug.

DRUG

Placebo

Participants will be randomized to receive either ammonium chloride or placebo. Participants will receive randomized drug in combination with IV bumetanide, bendroflumethiazide, and amiloride. Following a washout period, participants will be crossed over to the alternate drug.

Locations (1)

Yale University

New Haven, Connecticut, United States